The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Change of Website Address

8 Jan 2020 07:00

RNS Number : 0638Z
Asimilar Group PLC
08 January 2020
 

 

Asimilar Group plc

("Asimilar" or the "Company")

£6.8 million Equity Placing at 40 pence per share with Warrants

Asimilar Group Plc, the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), is pleased to announce that it has raised £6.8 million (gross) of new equity by way of a placing (the "Placing") of 17,000,000 new Ordinary Shares in the Company (the "Placing Shares") at a price of 40 pence per Ordinary Share with existing and new investors.

A warrant will be issued for every Placing Share subscribed for as part of the Placing exercisable at 130 pence per Ordinary Share from the date of issue up to 31 December 2021 ("Warrant"), with an accelerated exercise provision in the event that the mid-market price for Asimilar's Ordinary Shares reaches 280 pence per Ordinary Share for 5 consecutive business days. The Warrants will be required to be exercised within 21 calendar days of such an event or otherwise will lapse. Exercise of all the Warrants in the Company issued as part of the Placing would raise a further £22.1 million for the Company.

Investors that have committed to subscribe for Placing Shares include Nigel Wray and Chris Akers.

The proceeds of the Placing (after expenses) will be used, in conjunction with the funds currently held by Asimilar, to pursue the Company's investing policy of focusing on technology opportunities in the fields of big data, machine learning, telematics and the internet of things. The Company is currently actively considering a number of potential investment opportunities some of which may, or may not, lead to a reverse takeover at some time in the future.

Following completion of the Placing, Asimilar expects to have net cash available for investment of approximately £9.3 million.

The Placing will complete in 2 tranches, the first of which will complete on or around Friday 24 January 2020 and the second will complete on or around 13 March 2020.

Tranche 1

The £4,000,000 subscription monies payable for 10,000,000 of the Placing Shares ("Tranche 1 Placing Shares") are payable on 24 January 2020. Application will be made to the London Stock Exchange for the Tranche 1 Placing Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission of the Tranche 1 Placing Shares will become effective on or around 24 January 2020. 

Tranche 2

The £2,800,000 subscription monies payable for 7,000,000 of the Placing Shares ("Tranche 2 Placing Shares") are payable on 13 March 2020. Application will be made for admission of the Tranche 2 Placing Shares and it is expected that admission of the Tranche 2 Placing Shares will become effective on or around 13 March 2020.

All the Placing Shares will rank pari passu with the Company's existing Ordinary Shares in all respects.

Total Voting Rights

The current issued share capital of the Company is 82,132,276 Ordinary Shares, each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

Following the admission of the 11,562,500 Ordinary Shares issued pursuant to the placing announced on 18 December 2019 on or around 20 January 2020, the total issued share capital of the Company will be 93,694,776 Ordinary Shares, each with voting rights.

Following the admission of the 10,000,000 Tranche 1 Placing Shares on or around 24 January 2020, the total issued share capital of the Company will be 103,694,776 Ordinary Shares, each with voting rights.

Following the admission of the 7,000,000 Tranche 2 Placing Shares on or around 13 March 2020, the total issued share capital of the Company is expected to be 110,694,776 Ordinary Shares, each with voting rights.

As part of the Placing, Nigel Wray, who currently holds 12.19% of the issued share capital in the Company, has subscribed for 1,875,000 Ordinary Shares. Following admission of the Tranche 1 Placing Shares, he will hold approximately 11.5% of the issued share capital. Nigel Wray's participation in the Placing is considered to be a related party transaction under the AIM Rules for Companies. The Directors, having consulted with the Company's Nominated Adviser, consider that the terms of the participation of Mr Wray in the Placing are fair and reasonable insofar as the Company's shareholders are concerned.

New Website

Following the change of name announced on 23 December 2019, the Company's website address has been changed to www.asimilargroup.com.

 

John Taylor, Chairman of the Company said:

"We are excited by this premium equity placing which facilitates considerably greater capital flexibility for Asimilar to pursue a select number of potentially bold and transformative investment options. We look forward to keeping shareholders updated on our progress over the coming period".

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

**ENDS**

Enquiries

Asimilar Group plc

 

John Taylor, Non-Executive Chairman

via Wallbrook

 

 

Cairn Financial Advisers LLP

 

Sandy Jamieson, Liam Murray

Tel: +44 20 7213 0880

 

 

Peterhouse Capital Limited

 

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

 

 

Walbrook PR Ltd

Tel: +44 20 7933 8787

Paul McManus

Mob: +44 7980 541 893

Nick Rome

Mob: +44 7748 325 236

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKDLFBBFLEBBK
Date   Source Headline
30th Apr 20149:30 amRNSDirectorate Change
14th Apr 20147:00 amRNSBusiness Update
9th Apr 20149:00 amRNSReplacement announcement: Director resignation
9th Apr 20147:00 amRNSDirector Resignation
12th Mar 20147:00 amRNSNew Contract Wins valued at more than £0.5m
5th Mar 20147:00 amRNSNotice of AGM
21st Feb 20147:00 amRNSFinal Results
10th Feb 201411:00 amRNSTrading Update & Notice of Results
17th Dec 20137:00 amRNSChange of UK Head Office & Registered Office
28th Nov 201311:00 amRNSTrading Statement
16th Aug 20137:00 amRNSAppointment of Director and Grant of Share Options
26th Jun 20137:01 amRNSAppointment of Broker
26th Jun 20137:00 amRNSHalf Yearly Report
24th Jun 20137:00 amRNSNew contract wins
15th May 20138:41 amRNSResignation of NED & Appointment of Head of Ops
23rd Apr 201312:37 pmRNSResult of AGM
19th Apr 20137:00 amRNSChange of Adviser
18th Apr 20137:00 amRNSStmnt re Share Price Movement
28th Mar 20137:00 amRNSFinal Results for the Year Ended 30 September 2012
26th Mar 20139:47 amRNSPentagon Protection signs distribution agreement
18th Mar 20137:00 amRNSLoan Agreement
21st Feb 20137:00 amRNSNew Contract Win Valued at £1.9m
22nd Jan 20137:00 amRNSNew contract wins
8th Nov 20127:00 amRNSTrading Update and Result of General Meeting
8th Oct 20127:00 amRNSNew Contract Gains
18th Sep 20127:00 amRNSFurther Contract Gains
3rd Jul 20127:00 amRNSFurther Contract Gains
27th Jun 20127:00 amRNSIssue of Equity and Capitalisation of Loan
7th Jun 20129:17 amRNSInterim Results
30th Apr 20127:00 amRNSFurther Contract Gains
17th Apr 201212:24 pmRNSTotal Voting Rights
16th Apr 20124:33 pmRNSResult of AGM
16th Apr 20127:00 amRNSPENTAGON ANNOUNCES CONTRACT GAINS ACROSS THE GROUP
11th Apr 20124:10 pmRNSRestriction on New Share Authorities
3rd Apr 20123:10 pmRNSAdjournment of AGM
8th Mar 20129:30 amRNSNotice of AGM and Share Capital Reorganisation
7th Mar 201210:38 amRNSFinal Results
17th Nov 20117:00 amRNSTrading Update
8th Sep 20117:00 amRNSContract Gains
9th Aug 20117:00 amRNSContract Awards
28th Jul 20117:00 amRNSNew Contract Win
30th Jun 20119:01 amRNSHalf Yearly Report
24th May 201111:26 amRNSNew Contract Win
28th Apr 20114:52 pmRNSContract Award and Resignation of Director
15th Apr 20115:09 pmRNSResult of AGM
18th Mar 201110:00 amRNSDoc re. Report and Accounts / Related Pty Tran
18th Mar 20119:52 amRNSFinal Results
24th Nov 201012:36 pmRNSAppointment of Director
12th Nov 20104:30 pmRNSResult of GM
26th Oct 20107:00 amRNSAcquisition & Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.